Cell Cycle
Volume 19, 2020 - Issue 24
Open access
2,641
Views
13
CrossRef citations to date
0
Altmetric
Review
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine –possible therapeutic implication
Mehrdad Ghashghaeiniaa Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany;b Physiologisches Institut, Abteilung für Vegetative und Klinische Physiologie, Eberhard Karls University of Tübingen, Tübingen, GermanyCorrespondence[email protected]
https://orcid.org/0000-0002-1740-594XView further author information
, https://orcid.org/0000-0002-1740-594XView further author information
Peter Dreischerb Physiologisches Institut, Abteilung für Vegetative und Klinische Physiologie, Eberhard Karls University of Tübingen, Tübingen, GermanyView further author information
, Thomas Wiederb Physiologisches Institut, Abteilung für Vegetative und Klinische Physiologie, Eberhard Karls University of Tübingen, Tübingen, GermanyView further author information
& Martin Köberlec Department of Dermatology and Allergology, School of Medicine, Technical University of Munich, München, Germanyhttps://orcid.org/0000-0001-6825-2667View further author information
Pages 3399-3405
|
Received 26 Oct 2020, Accepted 30 Nov 2020, Published online: 11 Dec 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.